Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

Trial Profile

Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Autologous stem cell therapy (Primary) ; Filgrastim (Primary) ; Plerixafor (Primary)
  • Indications Liver cirrhosis
  • Focus Adverse reactions
  • Sponsors Proteonomix
  • Most Recent Events

    • 28 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top